DOYU Q4 2025 Earnings Massive EPS Surprise as Company Returns to Profitability Design Therapeutics Inc DSGN Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Gene Therapy Pipeline WKHS Q1 2026 Earnings EPS Misses Estimates by Wide Margin Amidst No Revenue Recognition Atlanta Braves Holdings Inc Series C BATRK Q1 2026 Earnings EPS Surprises Positively in Seasonally Quiet Quarter Shift4 Payments FOUR Q1 2026 Earnings A Narrow EPS Miss During Transition Quarter OFS Capital Corporation OFS Q1 2026 Earnings Massive EPS Beat Driven by Strong Net Investment Income